<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Co-Treatment of Chloroquine and Trametinib Inhibits Melanoma Cell Proliferation and Decreases Immune Cell Infiltration.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Co-Treatment of Chloroquine and Trametinib Inhibits Melanoma Cell Proliferation and Decreases Immune Cell Infiltration." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282877/bin/fonc-12-782877-g003.jpg"/> </div> <div class="text-side"> <h1>Co-Treatment of Chloroquine and Trametinib Inhibits Melanoma Cell Proliferation and Decreases Immune Cell Infiltration.</h1> <p>Trametinib and chloroquine treatments maintain melanoma pigmentation. (A) H&amp;E staining. Images were taken at 4x and 10x objectives. (B) Immunostaining of mouse melanoma tissue sections for MITF [brown]. Nuclei was counterstained in blue with Hematoxylin. The main images and the inserts were taken at 20X and 40X objective, respectively. Graph represents average percent area of tissues stained positive of MITF + S.E. 10 to 15 images of each treatment group were analyzed via Olympus imaging analysis system. The symbols "*" and "**" represent a p-value of less than 0.05 and 0.001 respectively.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35847840/" target="_blank">35847840</a></p><p>Type: Premalignant/Malignant, Category: Melanocytic</p>
</div> </div></div></body></html>